Residual risk of HIV, HCV and HBV in Canada

Transfusion and Apheresis Science

Volumn 56, Issue 3, 2017, Pages 389-391

  O'Brien, Sheila F ^a,b   Yi, Qi Long ^a,b   Fan, Wenli ^a   Scalia, Vito ^a   Goldman, Mindy ^a,b   Fearon, Margaret A ^a,c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Incidence; Multiplex NAT; Residual risk

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; CANADA; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; RISK ASSESSMENT; SEROCONVERSION; VIREMIA; VIRUS INFECTIVITY; RISK FACTOR;

CANADA; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK FACTORS;

EID: 85017341418     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2017.03.010     Document Type: Article

References (15)

1. Weusten, J., Van Drimmelen, J., Lelie, N., Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 42 (2002), 537–548.
2. Weusten, J., Vermeulen, M., Van Drimmelen, H., Lelie, N., Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 51 (2011), 203–215.
3. O'Brien, S.F., Yi, Q.-L., Fan, W., Scalia, V., Fearon, M.A., Allain, J.-P., Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang 103 (2012), 83–86.
4. Zou, S., Stramer, S.L., Notari, E.P., Kuhns, M.D., Krysztof, D., Musavi, F., et al. Current incidence and residual risk of hepatitis B infection in the United States. Transfusion 49 (2009), 1609–1620.
5. Korelitz, J.J., Busch, M.P., Kleinman, S.H., Williams, A.E., Gilcher, R.O., Schreiber, G.B., A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 37 (1997), 634–640.
6. Schreiber, G.B., Busch, M.P., Kleinman, S.H., Korelitz, J.J., The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334 (1996), 1685–1690.
7. Busch, M.P., Glynn, S.A., Stramer, S.L., Strong, D.M., Caglioti, S., Wright, D.J., et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45 (2005), 254–264.
8. Kleinman, S.H., Busch, M.P., Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 36 (2006), S23–S29.
9. Zou, S., Dorsey, K.A., Notari, E.P., Foster, G.A., Krysztof, D., Musavi, F., et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 50 (2010), 1495–1504.
10. Zou, S., Stramer, S.L., Notari, E.P., Kuhns, M.C., Krysztof, D., Musavi, F., et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 49 (2009), 1609–1620.
11. Safe supplies: uncovering donor behaviour. Annual review from the NHS Blood and Transplant/Public Health England Epidemiology Unit, 2014, London. 2015 http://www.gov.uk/government/collections/bloodborne-infections-in-blood-and-tissue-donors-bibd-guidance-data-and-analysis. [Accessed 3 November 2016].
12. Australia transfusion-transmissible infections in Australia: 2015 Surveillance Report., 2015, The Kirby Institute, The UNSW and Australian Red Cross Blood Service http://kirby.unsw.edu.au/. [Accessed 3 November 2016].
13. Taira, R., Satake, M., Momos, S., Hino, S., Suzuki, Y., Murokawa, H., et al. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion 53 (2013), 1393–1404.
14. Brambilla, D.J., Busch, M.P., Dodd, R.Y., Glynn, S.A., Kleinman, S.H., National Heart, Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study – III (REDS-III). A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors. Transfusion 57 (2017), 823–831.
15. Menitove, J.E., Leach Bennett, J., Tomasulo, P., Hatz, L.M., How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making. Transfusion 54 (2014), 753–757.